glp 1 not losing weight If you find that you're on Ozempic or other GLP-1 medications, your metabolism, or how quickly your body burns calories, may be the cause. It's sometimes called the “Ozempic I'm not losing weight yet:

Key takeaways include: Obesity drug coverage in Medicaid remains limited, with 13 state Medicaid programs covering GLP-1s for obesity treatment under fee-for-service (FFS) as of January 2026

Groups were as follows: saline/control antibody ( n = 8), Saline/-MSTN + -ActA ( n = 7), Sema/control antibody ( n = 7), and Sema /-MSTN + -ActA ( n = 8)

But the churn or enrollee turnover is so high in Medicaid that any longer-term, downstream cost savings would be very hard to come by, further exacerbating the budgetary problem

What theyre saying: There is a growing appreciation that the quality of weight loss is as important as the quantity of weight loss we believe that pemvidutide, if approved, could stand out as an attractive option for weight loss and weight maintenance. Altimmunes CMO Scott Harris The team effort The drugs: Regenerons trevogrumab and garetosmab are monoclonal antibodies

Key GLP agonist companies such as Sciwind, Boehringer Ingelheim, Merck, Eccogene, Suzhou, Regor Pharmaceuticals, Eli Lilly and Company, Neuraly, Carmot Therapeutics, Viking Therapeutics, Biolexis Therapeutics and others are evaluating new GLP agonist drugs to improve the treatment landscape

But again, these side effects dont usually last long